Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Clinical trial NCT01686152 · COMPLETED

Trial details

NCT number: NCT01686152
Sponsor: Teva Pharmaceuticals USA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2012-09-01
Primary completion: 2013-08-01
Enrollment: 589

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.